Stockreport

Cartesian Therapeutics to Participate in Upcoming Investor Conferences

Cartesian Therapeutics, Inc.  (RNAC) 
PDF GAITHERSBURG, Md., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRN [Read more]